Михаил Владимирович Иванов

Михаил Владимирович Иванов

Auto-generated profile, based on publicly available information

Михаил Владимирович Иванов

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Neurology, Psychiatry and Brain Research
Verified
Journal Article
Closed access
DSDmitry Sosin
Dmitry Sosin
DIDmitriy V Ivashchenko
Dmitriy V Ivashchenko
ZSZhannet Sozaeva
Zhannet Sozaeva
KRKristina Ryzhikova
Kristina Ryzhikova
VFVeronika Fadeeva
Veronika Fadeeva
MIMikhail Ivanov
Mikhail Ivanov

10 December 2023 in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
Verified
Journal Article
Open access
PDF file
VSV. V. Stanovaya
V. V. Stanovaya
ZGZ. T. Guseynova
Z. T. Guseynova
MIM. V. Ivanov
M. V. Ivanov
EBE. V. Bigday
E. V. Bigday
The formation of resistance is a key factor in curbing progress in the treatment of schizophrenia. In modern psychiatric practice, despite the emergence of new medical technologies, including the use of a wide arsenal of psychotropic medicinal effects, the frequency of manifestations of therapeutic resistance in the cohort of mentally ill is on average about 30%. The reasons for the formation of resistance identified to date are diverse and can be associated with both biological changes due to violations of the functioning of various neurotransmitter systems. so it is with non-compliance with the regimen of taking medications (drug noncompliance). Therapy-resistant schizophrenia is a serious clinical problem, since patients with such manifestations often feel the need for repeated hospitalizations, have more pronounced violations of social and professional functioning. It has been established that the formation of therapeutic resistance can occur both at the beginning of active treatment and in the process of psychopharmacotherapy. Therefore, it is important to identify predictors of therapeutic resistance, which will allow using methods to overcome it as soon as possible. This literature review examines both the main forms of therapeutic resistance and the features of its formation, as well as the possibilities of drug and non-drug therapy of resistant schizophrenia.Materials and methods. A literature review was performed in the PubMed database. The keywords types of therapeutic resistance, therapeutically resistant schizophrenia, antipsychotics, methods of anti-resistant effects. Inclusion criteria: randomized and non-randomized clinical trials, meta-analyses and systematic reviews, fulltext articles on therapeutic resistance in mentally ill patients and coping methods. Exclusion criteria: articles of poor quality. Results. The analysis of the literature data has shown the expediency of using not only clozapine, a first-line drug, for therapeutic resistance, but also modern drugs, primarily cariprazine, which, despite limited studies, have shown high efficacy both in combination therapy with clozapine and in monotherapy, in correcting stable productive, negative and cognitive symptoms. The use of augmentation with antidepressants, normotimic and glutamatergic drugs can be used to overcome resistance, but data on the effectiveness of this strategy are ambiguous. Of the non-medicinal methods of treating therapeutically resistant schizophrenia, the use of electroconvulsive therapy is recommended as the only method of biological effects that currently has an evidence base. Conclusions. According to the results of the literature review, the most studied, proven methods of overcoming therapeutically resistant schizophrenia are clozapine and electroconvulsive therapy. At the same time, taking into account the preliminary positive results of the use of third-generation antipsychotics, it can be considered appropriate to use them both in combination therapy and in monotherapy, with insufficient effectiveness of clozapine.

19 June 2023 in Psychiatry (Moscow) (Psikhiatriya)
Verified
Journal Article
Open access
PDF file
MTMarianna Tumova
Marianna Tumova
ISIRINA SHOSHINA
IRINA SHOSHINA
VSV. V. Stanovaya
V. V. Stanovaya
ZHZ. T. Huseinova
Z. T. Huseinova
TFThiago P Fernandes
Thiago P Fernandes
MIM. V. Ivanov
M. V. Ivanov
Background: increasing interest in visual disturbances in schizophrenia is connected with the fact that they are a potential biomarker for objectification of a mental condition. The nature of the relationship between visual disturbances and higher-level cognitive functions in schizophrenia remains understudied.The aim of the study was to investigate differences in visual information processing between individuals with paranoid schizophrenia and healthy individuals, and to analyze the relationship between visual system characteristics with clinical and cognitive factors.Patients and methods: thirty-three patients with the paranoid form of schizophrenia and 19 healthy subjects were included in the cross-sectional study. Cognitive impairment was assessed using a battery of BACS tests, and the severity of the mental state was assessed using the PANSS scale. Contrast sensitivity characteristics were measured by computer visocontrastometry.Results: the study found that the visual system of persons with schizophrenia is characterized by hypersensitivity in the high and midrange, but decreased sensitivity in the low-frequency range. Decreased sensitivity in the low-frequency range was associated with better cognitive functioning and less pronounced productive symptoms. Medium frequencies at the trend level correlated with the digit sequencing tests, assessing working memory, and verbal fluency, reflecting speed of information processing.Conclusions: our findings expand information on the character of the relationship between contrast sensitivity and cognitive function. The results of study will provide the basis for further research on the development of more effective non-medicinal methods to improve cognitive functioning.

1 March 2024 in Psychiatry (Moscow) (Psikhiatriya)
Verified
Journal Article
Open access
PDF file
AKA. V. Kosikova
A. V. Kosikova
ISIRINA SHOSHINA
IRINA SHOSHINA
SLS. I. Lyapunov
S. I. Lyapunov
ZGZ. T. Guseinova
Z. T. Guseinova
ILI. S. Lyapunov
I. S. Lyapunov
MIM. V. Ivanov
M. V. Ivanov
Background: schizophrenia is a severe mental illness characterized not only by cognitive but also sensory impairments, including the visual system. Research suggests impairments in contrast processing in schizophrenia, but evidence regarding the nature of these impairments is inconsistent. The theory of tremor modulation signal connects contrast sensitivity with the parameters of ocular microtremor – high-frequency and low-amplitude micromovements that are controlled by neurons of the nuclei of the brain stem. The parameters of ocular microtremor in psychopathology, in particular in schizophrenia, have not been described in the scientific literature.The aim of the study was to study the characteristics of contrast sensitivity and microtremor of the eyes of patients with schizophrenia.Patients and methods: to register contrast sensitivity, the method of computer visocontrastometry was used. Gabor elements were presented with spatial frequencies of 0.4, 1.0, 3.0, and 10 cycles/deg. Eye microtremor was recorded using a non-contact high-speed video recording method using an original optical system. The study involved 30 patients diagnosed as paranoid schizophrenia and 30 people without psychopathology and neurological diseases.Results: the contrast sensitivity of patients was reduced in the region of medium and high spatial frequencies compared with conditionally healthy controls, which may be associated with the chronic course of the disease. Ocular microtremor in the patient group was characterized by a lower frequency and a higher amplitude compared to the control group.Conclusions: contrast sensitivity and ocular microtremor are considered as potential markers for determining the functional state in schizophrenia, which requires further research and accumulation of experimental data.

29 December 2023 in Voprosy onkologii
Verified
Journal Article
Open access
АШАлександра Михайловна Шишкова
Александра Михайловна Шишкова
ВБВиктор Викторович Бочаров
Виктор Викторович Бочаров
ВМВладимир Алексеевич Михайлов
Владимир Алексеевич Михайлов
ТКТатьяна Артуровна Караваева
Татьяна Артуровна Караваева
МИМихаил Владимирович Иванов
Михаил Владимирович Иванов
АВАлександр Янович Вукс
Александр Янович Вукс
Introduction. Family members of people with cancer play a crucial role in looking after overall health of their loved ones, including physical, emotional, and social well-being. They also commonly experience the impact of the illness on themselves. Aim. To investigate the psychological status characteristics of relatives of cancer patients. Materials and methods. The study included 111 relatives of chronically ill patients: 30 relatives caring for cancer patients (mean age 47.6; SD 13.18 years); 33 relatives of patients with epilepsy (mean age 49; SD 12.93 years) and 48 relatives of patients with schizophrenia and schizotypal disorders (mean age 54.31; SD 9.46 years). The assessment tools used included the Symptom Checklist-90-Revised (SCL-90-R), the The Level of Relatives' Emotional Burnout (LREB), the Evaluation of Negative Consequences of Informal Caregiving, and the Family Environment Scale (FES). Results. Factor analysis using the principal component method identified six factors explaining 64.73 % of the total variance: the subjective severity of psychopathological symptoms, mobilization of individual psychological resources, social anxiety level, the severity of family interaction «facade», disease burden, and the patient's autonomy level factor. Comparison of the studied groups of relatives based on factor scale values demonstrated similarities in disease burden and perception of family situations. At the same time, relatives of cancer patients exhibited a higher severity and range of psychopathological symptoms and a decrease in the mobilization of psychological resources compared to relatives of patients with epilepsy and schizophrenia. Conclusion. Primary psychological interventions for relatives of oncology patients should address emotional responses to accumulated stress during interactions with the patient, exploration of existential experiences related to the loss of previous relationships with the patient, and psychological preparedness for accepting the death of a loved one in case of a fatal prognosis. Введение. Родственники больных со злокачественными новообразованиями играют значимую роль в поддержании их физического, эмоционального и социального благополучия и часто страдают от последствий болезни близкого. Цель исследования. Целью настоящего исследования являлось изучение особенностей психологического статуса родственников пациентов, страдающих злокачественными новообразованиями. Материал и методы. В исследовании приняли участие 111 родственников хронически больных: 30 родственников больных злокачественными новообразованиями (средний возраст — 47,6; SD — 13,18 лет); 33 родственника больных эпилепсией (средний возраст — 49; SD — 12,93 лет) и 48 родственников больных шизофренией и шизотипическими расстройствами (средний возраст — 54,31; SD — 9,46 лет). В качестве тестовых методов применялись: опросник выраженности психопатологической симптоматики SCL-90-R, методика «Уровень эмоционального выгорания родственников», методика «Оценка негативных последствий болезни близкого», шкала семейного окружения. Результаты. Факторный анализ методом главных компонент позволил выявить 6 факторов, объясняющих 64,73 % общей дисперсии: фактор субъективной выраженности психопатологической симптоматики, фактор степени мобилизации индивидуально-психологических ресурсов личности, фактор уровня социальной тревоги, фактор выраженности «фасадности» семейного взаимодействия, фактор выраженности «бремени» болезни, фактор уровня автономности пациента. Сопоставление исследуемых групп родственников по шкальным значениям факторов продемонстрировало сходство показателей бремени болезни и восприятия семейной ситуации. Вместе с тем в группе родственников пациентов, страдающих злокачественными новообразованиями, выявляется более высокий уровень и диапазон проявлений психопатологической симптоматики и снижение мобилизации психологических ресурсов личности, по сравнению с родственниками пациентов, страдающих эпилепсией и шизофренией. Выводы. В качестве основных направлений психологических интервенций для родственников онкологических больных необходимо рассматривать эмоциональное отреагирование стрессового напряжения,...

9 December 2019 in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
Verified
Journal Article
Open access
PDF file
DSDmitry Sosin
Dmitry Sosin
MIM. V. Ivanov
M. V. Ivanov
LML. M. Muslimova
L. M. Muslimova
DIDmitriy V Ivashchenko
Dmitriy V Ivashchenko
DSDmitry Sychev
Dmitry Sychev
According to modern data, about a third of patients suffering from schizophrenia are considered treatment resistant. The metabolism of about 20% of medicines and mainly psychotropic drugs is caused by the isoenzyme CYP2D6. This article presents the data of the CYP2D6 gene study as biomarkers for the treatment resistant schizophrenia. The study included 130 patients, men (65.4%) and women (34.6%) aged 18 to 60 years with schizophrenia. Based on the results, we found no effect of rs1065852 and rs3892097 polymorphisms gene CYP2D6 on treatment resistant schizophrenia.